Dr Reddy's Laboratories
Dr Reddy’s targets $1 bn revenue from generics
07 Mar 2011
The Hyderabad-based company, a leader in genetic drugs, sold $600 million worth of generics globally in the nine months of this fiscal ended 31 December
US court lifts stay on Dr Reddy’s generic allergy drug
01 Feb 2011
In a victory for generic drug makers over global pharmaceutical giants, a US court has allowed Dr Reddy's Laboratories to sell a generic version of Sanofi-Aventis SA's anti-allergy drug, Allegra D-24 in the US.
Dr Reddys shows steady Q1 performance
23 Jul 2010
